# Amryt Pharmaceuticals, INC. 401(k) Plan
Source: https://planprovider.pro/companies/amryt-pharmaceuticals-inc-401k-plan

> Amryt Pharmaceuticals, INC.'s 401(k) plan: 0 participants, plan year 2023 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2023.

## Plan Snapshot

- **Plan Sponsor:** Amryt Pharmaceuticals, INC.

- **Sponsor EIN:** 202960116

- **Sponsor Address:** 160 FEDERAL STREET, BOSTON, MA, 02110

- **Plan Type:** 401(k)

- **Total Participants:** 0

- **Total Assets:** $0

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|0|$0|$0|$0|

| 2023|55|$19.5M|$547,250|$1.4M|

| 2022|85|$17.4M|$415,492|$1.4M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| ROMEO,WIGGINS&COMPANY,LLP|Auditor|—|—|$0|

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$15,338|$9,138|—|—|—|

| 2023|$64,052|$35,984|—|—|—|

| 2022|$66,658|—|—|—|—|

## Similar Plans

- [Tiax LLC](https://planprovider.pro/companies/tiax-llc-401k-plan) — 54 participants

- [Repertoire Immune Medicines, INC](https://planprovider.pro/companies/repertoire-immune-medicines-inc-401k-plan) — 56 participants

- [Ring Therapeutics, INC.](https://planprovider.pro/companies/ring-therapeutics-inc-401k-plan) — 52 participants

- [Lifemine Therapeutics, INC.](https://planprovider.pro/companies/lifemine-therapeutics-inc-401k-plan) — 58 participants

- [Moma Therapeutics](https://planprovider.pro/companies/moma-therapeutics-401k-plan) — 59 participants

- [Invaio Sciences, INC.](https://planprovider.pro/companies/invaio-sciences-inc-401k-plan) — 60 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/amryt-pharmaceuticals-inc-401k-plan)

© 2026 PlanProvider.Pro